Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy Outcome of Ivermectin Plus Doxycycline in Treatment of RT-PCR Positive Adult Mild Covid-19 Cases: a Randomized Double Blind Placebo Controlled Trial

NCT04551755 is registered in ClinicalTrials.gov with Bangladesh Medical Research Council (BMRC) as lead sponsor.

NCT NCT04551755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy Outcome of Ivermectin Plus Doxycycline in Treatment of RT-PCR Positive Adult Mild Covid-19 Cases: a Randomized Double Blind Placebo Controlled Trial
Lead sponsor
Bangladesh Medical Research Council (BMRC)
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2020
Completion date
December 31, 2020
Enrollment
188 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19